2016
DOI: 10.1016/j.jval.2016.08.277
|View full text |Cite
|
Sign up to set email alerts
|

Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles